image

Investors

Corporate Profile

Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. Leveraging Nurix’s extensive expertise in E3 ligases together with proprietary DNA-encoded libraries, Nurix has built DELigase, an integrated discovery platform to identify and advance novel drug candidates that can modulate proteins within the cell.

Archived Events
Nurix Therapeutics ASH Annual Meeting
December 9, 2024 at 11:15 PM EST
Click here for webcast
San Diego
Piper Sandler 36th Annual Healthcare Conference
December 3, 2024 at 2:30 PM EST
Click here for webcast
New York City
Jefferies London Healthcare Conference
November 21, 2024 from 11:30 AM to 11:55 AM GMT
Click here for webcast
London, U.K.
Stifel Healthcare Conference
November 18, 2024 from 4:45 PM to 5:15 PM EST
Click here for webcast
New York, NY
Stephens Biotechnology Virtual Fireside Chats
November 14, 2024 from 2:30 PM to 3:15 PM EST
UBS Healthcare Conference
November 12, 2024 from 5:00 PM to 5:35 PM PST
Click here for webcast
Rancho Palos Verdes, CA
Truist BioPharma Symposium
November 7, 2024 from 10:30 AM to 11:20 AM EST
New York, NY
Baird 2024 Global Healthcare Conference
September 10, 2024 from 9:50 AM to 10:20 AM EDT
ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit
September 10, 2024 from 9:05 AM to 9:25 AM EDT
H.C. Wainwright 26th Annual Global Investment Conference
September 9, 2024 from 9:30 AM to 10:00 AM EDT
Click here for webcast
Corporate Presentations
Scientific Presentation
Print Page
Email Alerts
RSS Feeds
Contact IR